Search Results 11-20 of 8017 for zerona

1. A Study to Investigate Minimal Detectable Change in Heart Rate Variability - Mayo Clinic

   Inclusion Criteria: Eligible participants will be active, healthy individuals between the ages of 18 and 30 who are in good health. Exclusion Criteria:.

2. Calcium release deficiency syndrome (CRDS) - Mayo Clinic

   The purpose of this research study is to establish a large registry of individuals diagnosed with CRDS, along with individuals that have genetic changes that ...

3. Presentations and Publications - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

   Review Dr. Sarkaria's published research about glioblastoma, including targeted therapy, patient-derived xenografts, brain metastases, temozolomide (TMZ) ...

4. A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) - Mayo Clinic

   A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) · Overview · Participation eligibility.

5. Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma - Mayo Clinic

   Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...

6. A Study of Lower Body Negative Pressure for Research and Development on Non-Invasive Monitoring Devices - Mayo Clinic

   The purpose of this study is to see how the body responds to different levels of lower body negative pressure, specifically how the peripheral blood flow ...

7. Encephalitis - Doctors and departments - Mayo Clinic

   Learn about this potentially fatal condition associated with inflammation of the brain and what you can do to prevent it.

8. Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma - Mayo Clinic

   The purpose of this study is to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS ( ...

9. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   This study observes the clinical efficacy of combining proton SBRT with PD-1 blockade immunotherapy in both the locoregionally recurrent and metastatic settings ...

10. A Study to Evaluate IMGN632 with Venetoclax and/or Azacitidine to Treat Patients with CD123-Positive Acute Myeloid Leukemia - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...